1. Home
  2. Labeler Index
  3. A-s Medication Solutions
  4. 50090-3941
  5. Product Images: Aripiprazole

Product Images Aripiprazole

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Aripiprazole NDC 50090-3941 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - aripiprazole figure 1

Figure 1 - aripiprazole figure 1

This is a table depicting the effects of various drugs on the absorption of Aripiprazole. The drugs are categorized into CYP3A4 inhibitors, CYP2D6 inhibitors, gastric acid blockers, and other types of drugs. The table shows the effects of each drug on the PK Aipprazol Fad Change and S0% CI. The values displayed in the table are in percentages, indicating the change in absorption relative to the reference (without interacting drug).*

Figure 2 - aripiprazole figure 2

Figure 2 - aripiprazole figure 2

The text appears to be a table displaying the effect of different drugs on aripiprazole. The drugs are divided into two groups, gastric acid blockers and "other" drugs. The effects are measured as a change relative to the reference (without interacting drug) and are presented as percentages with a confidence interval. Specific drugs listed include "vaproate" and "ocazapm", but the information is incomplete.*

Figure 3 - aripiprazole figure 3

Figure 3 - aripiprazole figure 3

Effect of aripiprazole on other drugs is the topic of this text. The text includes a table showing the change relative to reference for different drugs such as clozapine, omeprazole, risperidone, and escitalopram, when taken with aripiprazole. The table also shows the enzymes affected by aripiprazole.*

Figure 4 - aripiprazole figure 4

Figure 4 - aripiprazole figure 4

This is a description of various special populations for a medical study which includes information about gender, hepatic impairment, and renal impairment. The text mentions the percentage change and relative to a reference for Aviiprazcie Fod. There is not enough information given to fully understand the purpose of the study or the results obtained.*

Figure 5 - aripiprazole figure 5

Figure 5 - aripiprazole figure 5

Figure-6 - aripiprazole figure 6

Figure-6 - aripiprazole figure 6

Figure-7 - aripiprazole figure 7

Figure-7 - aripiprazole figure 7

Figure-8 - aripiprazole figure 8

Figure-8 - aripiprazole figure 8

The text describes a table that seems to show the proportion of subjects with relapse in a study involving a drug named "ARFPRAZOLE" and another drug named "PucEsq". The table is divided into two columns, with the first column including numbers that represent the number of subjects, and the second showing the Proportion of subjects who relapsed. However, the table is not readable due to errors in the text obtained by .*

aripiprazole chemical structure - aripiprazole structure

aripiprazole chemical structure - aripiprazole structure

Label Image - lbl500903941

Label Image - lbl500903941

This is a product with the serial number 9955-0, containing 15g of a medication called "ARTPIPRAZOLE". It comes in the form of 26 unit dose tablets. The other text appears to be unreadable.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.